Eddie Sullivan, SAB Biotherapeutics president and CEO
April 26, 2023 08:30 AM EDT
R&D
Coronavirus

South Dako­ta-based Covid-19 trans­genic cow an­ti­body start­up claims its first PhI­II win

Zachary Brennan

Senior Editor

SAB Bio­ther­a­peu­tics, known for col­lect­ing and dis­till­ing an­ti­bod­ies from cows with hu­man­ized im­mune sys­tems, on Wednes­day said a Phase III tri­al it ran for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times